Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Sanz Ortiz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 25, 2006
Informed consent and sedationJaime Sanz-Ortiz
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 1, 2008
Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin levelJaime Sanz Ortiz
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Chemotherapy at the end of life: up until when?Jaime Sanz Ortiz
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 18, 2008
Protein energy malnutrition (PEM) in cancer patientsJaime Sanz Ortiz, José Andrés Moreno Nogueira, Abelardo García de Lorenzo y Mateos
Cancer Research|November 3, 2004
Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2Pedro Jose Real, Yeyu Cao, Renxiao Wang, et al.
The Laryngoscope|July 6, 2004
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynxFernando Rivera, Maria E Vega-Villegas, Marta F López-Brea, et al.
European Journal of Pain (London, England)|July 4, 2006
Oncologists' perceptions of cancer pain management in Spain: the real and the idealJoan Carulla Torrent, Carlos Jara Sánchez, Jaime Sanz Ortiz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2007
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropeniaFernando Rivera, María E Vega-Villegas, Marta F López-Brea, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2007
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)Fernando Rivera, M Eugenia Vega-Villegas, Marta López-Brea, et al.
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancerFernando Rivera, María Eugenia Vega-Villegas, Carlos López, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 25, 2006
Informed consent and sedationJaime Sanz-Ortiz
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 1, 2008
Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin levelJaime Sanz Ortiz
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Chemotherapy at the end of life: up until when?Jaime Sanz Ortiz
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 18, 2008
Protein energy malnutrition (PEM) in cancer patientsJaime Sanz Ortiz, José Andrés Moreno Nogueira, Abelardo García de Lorenzo y Mateos
Cancer Research|November 3, 2004
Breast cancer cells can evade apoptosis-mediated selective killing by a novel small molecule inhibitor of Bcl-2Pedro Jose Real, Yeyu Cao, Renxiao Wang, et al.
The Laryngoscope|July 6, 2004
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynxFernando Rivera, Maria E Vega-Villegas, Marta F López-Brea, et al.
European Journal of Pain (London, England)|July 4, 2006
Oncologists' perceptions of cancer pain management in Spain: the real and the idealJoan Carulla Torrent, Carlos Jara Sánchez, Jaime Sanz Ortiz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2007
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropeniaFernando Rivera, María E Vega-Villegas, Marta F López-Brea, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2007
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)Fernando Rivera, M Eugenia Vega-Villegas, Marta López-Brea, et al.
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancerFernando Rivera, María Eugenia Vega-Villegas, Carlos López, et al.
Pageof 2